{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:57:08Z","timestamp":1792580228728,"version":"4.5.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NS 32352"],"award-info":[{"award-number":["NS 32352"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NS44233"],"award-info":[{"award-number":["NS44233"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NS92625"],"award-info":[{"award-number":["NS92625"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U54 NS065736"],"award-info":[{"award-number":["U54 NS065736"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011542","name":"Center for Clinical and Translational Science, Mayo Clinic","doi-asserted-by":"crossref","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100011542","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013327","name":"Lundbeck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s40120-019-00152-9","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T12:03:34Z","timestamp":1566907414000},"page":"307-324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Neurogenic Orthostatic Hypotension in\n            Parkinson Disease: A Primer"],"prefix":"10.1007","volume":"8","author":[{"given":"Jeremy K.","family":"Cutsforth-Gregory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip A.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"issue":"4","key":"152_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","volume":"27","author":"JG Goldman","year":"2014","unstructured":"Goldman JG, Postuma R. Premotor and non-motor features of\n                    Parkinson\u2019s disease. Curr Opin Neurol. 2014;27(4):434\u201341.","journal-title":"Curr Opin Neurol"},{"issue":"Suppl 12","key":"152_CR2","first-page":"S308","volume":"17","author":"KE Lyons","year":"2011","unstructured":"Lyons KE, Pahwa R. The impact and management of non-motor symptoms\n                    of Parkinson\u2019s disease. Am J Manag Care. 2011;17[Suppl\n                    12]:S308\u201314.","journal-title":"Am J Manag Care"},{"issue":"6","key":"152_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ene.13002","volume":"23","author":"MC Wen","year":"2016","unstructured":"Wen MC, Chan LL, Tan LC, Tan EK. Depression, anxiety, and apathy in\n                    Parkinson\u2019s disease: insights from neuroimaging studies. Eur J Neurol.\n                    2016;23(6):1001\u201319.","journal-title":"Eur J Neurol"},{"issue":"6","key":"152_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.parkreldis.2006.12.014","volume":"13","author":"T Ziemssen","year":"2007","unstructured":"Ziemssen T, Reichmann H. Non-motor dysfunction in Parkinson\u2019s\n                    disease. Parkinson Relat Disord. 2007;13(6):323\u201332.","journal-title":"Parkinson Relat Disord."},{"issue":"2","key":"152_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/cphy.c130026","volume":"4","author":"DS Goldstein","year":"2014","unstructured":"Goldstein DS. Dysautonomia in Parkinson disease. Compr Physiol.\n                    2014;4(2):805\u201326.","journal-title":"Compr Physiol."},{"issue":"8","key":"152_CR6","doi-asserted-by":"publisher","first-page":"a009258","DOI":"10.1101\/cshperspect.a009258","volume":"2","author":"DW Dickson","year":"2012","unstructured":"Dickson DW. Parkinson\u2019s disease and parkinsonism: neuropathology.\n                    Cold Spring Harb Perspect Med. 2012;2(8):a009258.","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"3","key":"152_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.27186","volume":"33","author":"EA Coon","year":"2018","unstructured":"Coon EA, Cutsforth-Gregory JK, Benarroch EE. Neuropathology of\n                    autonomic dysfunction in synucleinopathies. Mov Disord.\n                    2018;33(3):349\u201358.","journal-title":"Mov Disord"},{"key":"152_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/B978-0-444-53491-0.00021-3","volume":"117","author":"H Kaufmann","year":"2013","unstructured":"Kaufmann H, Goldstein DS. Autonomic dysfunction in Parkinson\n                    disease. Handb Clin Neurol. 2013;117:259\u201378.","journal-title":"Handb Clin Neurol."},{"issue":"8","key":"152_CR9","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","volume":"264","author":"CH Gibbons","year":"2017","unstructured":"Gibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a\n                    consensus panel for the screening, diagnosis, and treatment of neurogenic\n                    orthostatic hypotension and associated supine hypertension. J Neurol.\n                    2017;264(8):1567\u201382.","journal-title":"J Neurol"},{"issue":"2","key":"152_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the\n                    definition of orthostatic hypotension, neurally mediated syncope and the\n                    postural tachycardia syndrome. Clin Auton Res.\n                    2011;21(2):69\u201372.","journal-title":"Clin Auton Res"},{"key":"152_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/VHRM.S53983","volume":"10","author":"SH Isaacson","year":"2014","unstructured":"Isaacson SH, Skettini J. Neurogenic orthostatic hypotension in\n                    Parkinson\u2019s disease: evaluation, management, and emerging role of droxidopa.\n                    Vasc Health Risk Manag. 2014;10:169\u201376.","journal-title":"Vasc Health Risk Manag."},{"issue":"1","key":"152_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12883-018-1129-x","volume":"18","author":"DO Claassen","year":"2018","unstructured":"Claassen DO, Adler CH, Hewitt LA, Gibbons C. Characterization of\n                    the symptoms of neurogenic orthostatic hypotension and their impact from a\n                    survey of patients and caregivers. BMC Neurol. 2018;18(1):125.","journal-title":"BMC Neurol."},{"issue":"1","key":"152_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/CIRCULATIONAHA.108.805887","volume":"119","author":"DS Goldstein","year":"2009","unstructured":"Goldstein DS, Sharabi Y. Neurogenic orthostatic hypotension: a\n                    pathophysiological approach. Circulation. 2009;119(1):139\u201346.","journal-title":"Circulation"},{"issue":"11","key":"152_CR14","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1586\/14779072.2015.1095090","volume":"13","author":"PK Jones","year":"2015","unstructured":"Jones PK, Shaw BH, Raj SR. Orthostatic hypotension: managing a\n                    difficult problem. Expert Rev Cardiovasc Ther.\n                    2015;13(11):1263\u201376.","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"21","key":"152_CR15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","volume":"39","author":"M Brignole","year":"2018","unstructured":"Brignole M, Moya A, de Lange FJ, et al. 2018 ESC guidelines for the\n                    diagnosis and management of syncope. Eur Heart J.\n                    2018;39(21):1883\u2013948.","journal-title":"Eur Heart J"},{"issue":"3","key":"152_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1042\/CS20060091","volume":"112","author":"W Wieling","year":"2007","unstructured":"Wieling W, Krediet CT, van Dijk N, Linzer M, Tschakovsky ME.\n                    Initial orthostatic hypotension: review of a forgotten condition. Clin Sci\n                    (Lond). 2007;112(3):157\u201365.","journal-title":"Clin Sci (Lond)."},{"issue":"6","key":"152_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMcp074189","volume":"358","author":"R Freeman","year":"2008","unstructured":"Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N\n                    Engl J Med. 2008;358(6):615\u201324.","journal-title":"N Engl J Med."},{"issue":"21","key":"152_CR18","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1093\/eurheartj\/ehp298","volume":"30","author":"A Moya","year":"2009","unstructured":"Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis\n                    and management of syncope (version 2009): the Task Force for the Diagnosis and\n                    Management of Syncope of the European Society of Cardiology (ESC). Eur Heart J.\n                    2009;30(21):2631\u201371.","journal-title":"Eur Heart J"},{"issue":"3","key":"152_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jpeds.2010.09.004","volume":"158","author":"JM Stewart","year":"2011","unstructured":"Stewart JM, Clarke D. \u201cHe\u2019s dizzy when he stands up\u201d: an\n                    introduction to initial orthostatic hypotension. J Pediatr.\n                    2011;158(3):499\u2013504.","journal-title":"J Pediatr"},{"issue":"8","key":"152_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","volume":"13","author":"H Kaufmann","year":"2015","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA. Droxidopa in neurogenic\n                    orthostatic hypotension. Expert Rev Cardiovasc Ther.\n                    2015;13(8):875\u201391.","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"5","key":"152_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1474-4422(08)70088-7","volume":"7","author":"PA Low","year":"2008","unstructured":"Low PA, Singer W. Management of neurogenic orthostatic hypotension:\n                    an update. Lancet Neurol. 2008;7(5):451\u20138.","journal-title":"Lancet Neurol."},{"issue":"13 Suppl","key":"152_CR22","first-page":"s248","volume":"21","author":"PA Low","year":"2015","unstructured":"Low PA. Neurogenic orthostatic hypotension: pathophysiology and\n                    diagnosis. Am J Manag Care. 2015;21[13 Suppl]:s248\u201357.","journal-title":"Am J Manag Care."},{"issue":"Suppl 1","key":"152_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s10286-007-1004-0","volume":"18","author":"D Robertson","year":"2008","unstructured":"Robertson D. The pathophysiology and diagnosis of orthostatic\n                    hypotension. Clin Auton Res. 2008;18[Suppl 1]:2\u20137.","journal-title":"Clin Auton Res"},{"issue":"11","key":"152_CR24","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jacc.2018.05.079","volume":"72","author":"R Freeman","year":"2018","unstructured":"Freeman R, Abuzinadah AR, Gibbons C, Jones P, Miglis MG, Sinn DI.\n                    Orthostatic hypotension: JACC state-of-the-art review. J Am Coll Cardiol.\n                    2018;72(11):1294\u2013309.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"152_CR25","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","volume":"17","author":"DC Velseboer","year":"2011","unstructured":"Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM.\n                    Prevalence of orthostatic hypotension in Parkinson\u2019s disease: a systematic\n                    review and meta-analysis. Parkinson Relat Disord.\n                    2011;17(10):724\u20139.","journal-title":"Parkinson Relat Disord."},{"issue":"5","key":"152_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/mds.26079","volume":"30","author":"JA Palma","year":"2015","unstructured":"Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, et al.\n                    Orthostatic hypotension in Parkinson disease: how much you fall or how low you\n                    go? Mov Disord. 2015;30(5):639\u201345.","journal-title":"Mov Disord"},{"issue":"3","key":"152_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/mds.27268","volume":"33","author":"A Merola","year":"2018","unstructured":"Merola A, Romagnolo A, Rosso M, et al. Autonomic dysfunction in\n                    Parkinson\u2019s disease: a prospective cohort study. Mov Disord.\n                    2018;33(3):391\u20137.","journal-title":"Mov Disord"},{"issue":"8","key":"152_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.parkreldis.2011.05.020","volume":"17","author":"AD Ha","year":"2011","unstructured":"Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic\n                    orthostatic hypotension in patients with Parkinson\u2019s disease and atypical\n                    parkinsonism. Parkinson Relat Disord. 2011;17(8):625\u20138.","journal-title":"Parkinson Relat Disord."},{"issue":"5","key":"152_CR29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/jnnp.63.5.584","volume":"63","author":"JM Senard","year":"1997","unstructured":"Senard JM, Rai S, Lapeyre-Mestre M, et al. Prevalence of\n                    orthostatic hypotension in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry.\n                    1997;63(5):584\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"152_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2016.09.013","volume":"33","author":"A Merola","year":"2016","unstructured":"Merola A, Romagnolo A, Rosso M, et al. Orthostatic hypotension in\n                    Parkinson\u2019s disease: does it matter if asymptomatic? Parkinson Relat Disord.\n                    2016;33:65\u201371.","journal-title":"Parkinson Relat Disord."},{"issue":"3","key":"152_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/mdc3.12478","volume":"4","author":"JA Palma","year":"2017","unstructured":"Palma JA, Kaufmann H. Epidemiology, diagnosis, and management of\n                    neurogenic orthostatic hypotension. Mov Disord Clin Pract.\n                    2017;4(3):298\u2013308.","journal-title":"Mov Disord Clin Pract."},{"issue":"16","key":"152_CR32","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1212\/WNL.0000000000002030","volume":"85","author":"CH Gibbons","year":"2015","unstructured":"Gibbons CH, Freeman R. Clinical implications of delayed orthostatic\n                    hypotension: a 10-year follow-up study. Neurology.\n                    2015;85(16):1362\u20137.","journal-title":"Neurology."},{"issue":"3","key":"152_CR33","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jgs.14563","volume":"65","author":"C Finucane","year":"2017","unstructured":"Finucane C, O\u2019Connell MD, Donoghue O, Richardson K, Savva GM, Kenny\n                    RA. Impaired orthostatic blood pressure recovery is associated with unexplained\n                    and injurious falls. J Am Geriatr Soc. 2017;65(3):474\u201382.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"152_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1212\/01.wnl.0000266593.50534.e8","volume":"69","author":"D Verbaan","year":"2007","unstructured":"Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van\n                    Hilten JJ. Patient-reported autonomic symptoms in Parkinson disease. Neurology.\n                    2007;69(4):333\u201341.","journal-title":"Neurology."},{"issue":"12","key":"152_CR35","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, et al. MDS research criteria for\n                    prodromal Parkinson\u2019s disease. Mov Disord.\n                    2015;30(12):1600\u201311.","journal-title":"Mov Disord"},{"key":"152_CR36","first-page":"475854","volume":"2014","author":"SM Fereshtehnejad","year":"2014","unstructured":"Fereshtehnejad SM, Lokk J. Orthostatic hypotension in patients with\n                    Parkinson\u2019s disease and atypical parkinsonism. Parkinsons Dis.\n                    2014;2014:475854.","journal-title":"Parkinsons Dis."},{"issue":"1","key":"152_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s10286-006-0317-8","volume":"16","author":"DS Goldstein","year":"2006","unstructured":"Goldstein DS. Orthostatic hypotension as an early finding in\n                    Parkinson\u2019s disease. Clin Auton Res. 2006;16(1):46\u201354.","journal-title":"Clin Auton Res"},{"issue":"2","key":"152_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10286-007-0396-1","volume":"17","author":"DS Goldstein","year":"2007","unstructured":"Goldstein DS, Sharabi Y, Karp BI, et al. Cardiac sympathetic\n                    denervation preceding motor signs in Parkinson disease. Clin Auton Res.\n                    2007;17(2):118\u201321.","journal-title":"Clin Auton Res"},{"issue":"4","key":"152_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10286-012-0165-7","volume":"22","author":"V Milazzo","year":"2012","unstructured":"Milazzo V, Di Stefano C, Servo S, Zibetti M, Lopiano L, Maule S.\n                    Neurogenic orthostatic hypotension as the initial feature of Parkinson disease.\n                    Clin Auton Res. 2012;22(4):203\u20136.","journal-title":"Clin Auton Res"},{"issue":"1","key":"152_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","volume":"14","author":"A Schrag","year":"2015","unstructured":"Schrag A, Horsfall L, Walters K, Noyce A, Petersen I. Prediagnostic\n                    presentations of Parkinson\u2019s disease in primary care: a case\u2013control study.\n                    Lancet Neurol. 2015;14(1):57\u201364.","journal-title":"Lancet Neurol."},{"issue":"6","key":"152_CR41","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1212\/01.WNL.0000138500.73671.DC","volume":"63","author":"H Kaufmann","year":"2004","unstructured":"Kaufmann H, Nahm K, Purohit D, Wolfe D. Autonomic failure as the\n                    initial presentation of Parkinson disease and dementia with Lewy bodies.\n                    Neurology. 2004;63(6):1093\u20135.","journal-title":"Neurology."},{"issue":"4","key":"152_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.7326\/0003-4819-28-4-723","volume":"28","author":"G Nylin","year":"1948","unstructured":"Nylin G, Levander M. Studies on the circulation with the aid of\n                    tagged erythrocytes in a case of orthostatic hypotension (asympathicotomic\n                    hypotension). Ann Intern Med. 1948;28(4):723\u201346.","journal-title":"Ann Intern Med"},{"issue":"12","key":"152_CR43","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1212\/WNL.0000000000003737","volume":"88","author":"W Singer","year":"2017","unstructured":"Singer W, Berini SE, Sandroni P, et al. Pure autonomic failure:\n                    predictors of conversion to clinical CNS involvement. Neurology.\n                    2017;88(12):1129\u201336.","journal-title":"Neurology."},{"issue":"13","key":"152_CR44","doi-asserted-by":"publisher","first-page":"e1245","DOI":"10.1212\/WNL.0000000000006243","volume":"91","author":"G Giannini","year":"2018","unstructured":"Giannini G, Calandra-Buonaura G, Asioli GM, et al. The natural\n                    history of idiopathic autonomic failure: the IAF-BO cohort study. Neurology.\n                    2018;91(13):e1245\u201354.","journal-title":"Neurology."},{"issue":"2","key":"152_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ana.24877","volume":"81","author":"H Kaufmann","year":"2017","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA, et al. Natural history\n                    of pure autonomic failure: a United States prospective cohort. Ann Neurol.\n                    2017;81(2):287\u201397.","journal-title":"Ann Neurol"},{"issue":"8","key":"152_CR46","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"SM Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF,\n                    Postuma RB. New clinical subtypes of Parkinson disease and their longitudinal\n                    progression: a prospective cohort comparison with other phenotypes. JAMA Neurol.\n                    2015;72(8):863\u201373.","journal-title":"JAMA Neurol."},{"issue":"18","key":"152_CR47","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1212\/WNL.0000000000002086","volume":"85","author":"DS Goldstein","year":"2015","unstructured":"Goldstein DS, Holmes C, Sharabi Y, Wu T. Survival in\n                    synucleinopathies: a prospective cohort study. Neurology.\n                    2015;85(18):1554\u201361.","journal-title":"Neurology."},{"issue":"4","key":"152_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","volume":"28","author":"A Fanciulli","year":"2018","unstructured":"Fanciulli A, Jordan J, Biaggioni I, et al. Consensus statement on\n                    the definition of neurogenic supine hypertension in cardiovascular autonomic\n                    failure by the American Autonomic Society (AAS) and the European Federation of\n                    Autonomic Societies (EFAS): endorsed by the European Academy of Neurology (EAN)\n                    and the European Society of Hypertension (ESH). Clin Auton Res.\n                    2018;28(4):355\u201362.","journal-title":"Clin Auton Res"},{"issue":"2","key":"152_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10286-015-0336-4","volume":"26","author":"A Fanciulli","year":"2016","unstructured":"Fanciulli A, Gobel G, Ndayisaba JP, et al. Supine hypertension in\n                    Parkinson\u2019s disease and multiple system atrophy. Clin Auton Res.\n                    2016;26(2):97\u2013105.","journal-title":"Clin Auton Res"},{"issue":"8","key":"152_CR50","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40263-017-0453-9","volume":"31","author":"J Baker","year":"2017","unstructured":"Baker J, Kimpinski K. Management of supine hypertension\n                    complicating neurogenic orthostatic hypotension. CNS Drugs.\n                    2017;31(8):653\u201363.","journal-title":"CNS Drugs"},{"issue":"1\u20132","key":"152_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2011.06.047","volume":"310","author":"Y Sharabi","year":"2011","unstructured":"Sharabi Y, Goldstein DS. Mechanisms of orthostatic hypotension and\n                    supine hypertension in Parkinson disease. J Neurol Sci.\n                    2011;310(1\u20132):123\u20138.","journal-title":"J Neurol Sci"},{"issue":"5","key":"152_CR52","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/HYPERTENSIONAHA.109.136853","volume":"54","author":"EM Garland","year":"2009","unstructured":"Garland EM, Gamboa A, Okamoto L, et al. Renal impairment of pure\n                    autonomic failure. Hypertension. 2009;54(5):1057\u201361.","journal-title":"Hypertension"},{"issue":"10","key":"152_CR53","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.amjhyper.2006.02.016","volume":"19","author":"S Maule","year":"2006","unstructured":"Maule S, Milan A, Grosso T, Veglio F. Left ventricular hypertrophy\n                    in patients with autonomic failure. Am J Hypertens.\n                    2006;19(10):1049\u201354.","journal-title":"Am J Hypertens"},{"issue":"9205","key":"152_CR54","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0140-6736(99)05320-9","volume":"355","author":"TD Vagaonescu","year":"2000","unstructured":"Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H.\n                    Hypertensive cardiovascular damage in patients with primary autonomic failure.\n                    Lancet. 2000;355(9205):725\u20136.","journal-title":"Lancet"},{"issue":"6","key":"152_CR55","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1161\/HYPERTENSIONAHA.115.05913","volume":"66","author":"V Milazzo","year":"2015","unstructured":"Milazzo V, Maule S, Di Stefano C, et al. Cardiac organ damage and\n                    arterial stiffness in autonomic failure: comparison with essential hypertension.\n                    Hypertension. 2015;66(6):1168\u201375.","journal-title":"Hypertension"},{"key":"152_CR56","first-page":"473","volume":"28","author":"JA Palma","year":"2018","unstructured":"Palma JA, Redel-Traub G, Porciuncula A, et al. The impact of supine\n                    hypertension on target organ damage and mortality in patients with neurogenic\n                    orthostatic hypotension. Clin Auton Res. 2018;28:473.","journal-title":"Clin Auton Res"},{"issue":"10","key":"152_CR57","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/00004872-199816100-00006","volume":"16","author":"M Plaschke","year":"1998","unstructured":"Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C.\n                    Twenty-four-hour blood pressure profile and blood pressure responses to head-up\n                    tilt tests in Parkinson\u2019s disease and multiple system atrophy. J Hypertens.\n                    1998;16(10):1433\u201341.","journal-title":"J Hypertens"},{"issue":"2","key":"152_CR58","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/HYPERTENSIONAHA.108.124552","volume":"53","author":"LE Okamoto","year":"2009","unstructured":"Okamoto LE, Gamboa A, Shibao C, et al. Nocturnal blood pressure\n                    dipping in the hypertension of autonomic failure. Hypertension.\n                    2009;53(2):363\u20139.","journal-title":"Hypertension"},{"issue":"10","key":"152_CR59","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jash.2016.07.009","volume":"10","author":"H Kaufmann","year":"2016","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Hewitt LA, Rowse GJ, White WB.\n                    Effects of the novel norepinephrine prodrug, droxidopa, on ambulatory blood\n                    pressure in patients with neurogenic orthostatic hypotension. J Am Soc\n                    Hypertens. 2016;10(10):819\u201326.","journal-title":"J Am Soc Hypertens."},{"key":"152_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.06.032","volume":"56","author":"V Milazzo","year":"2018","unstructured":"Milazzo V, Di Stefano C, Vallelonga F, et al. Reverse blood\n                    pressure dipping as marker of dysautonomia in Parkinson disease. Parkinson Relat\n                    Disord. 2018;56:82\u20137.","journal-title":"Parkinson Relat Disord."},{"issue":"2","key":"152_CR61","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0828-282X(07)70733-X","volume":"23","author":"FS Routledge","year":"2007","unstructured":"Routledge FS, McFetridge-Durdle JA, Dean CR. Night-time blood\n                    pressure patterns and target organ damage: a review. Can J Cardiol.\n                    2007;23(2):132\u20138.","journal-title":"Can J Cardiol"},{"issue":"6","key":"152_CR62","first-page":"808","volume":"27","author":"LC Tan","year":"1998","unstructured":"Tan LC, Tan AK, Tjia HT. The profile of hospitalised patients with\n                    Parkinson\u2019s disease. Ann Acad Med Singapore.\n                    1998;27(6):808\u201312.","journal-title":"Ann Acad Med Singapore"},{"issue":"9","key":"152_CR63","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/mds.20485","volume":"20","author":"H Woodford","year":"2005","unstructured":"Woodford H, Walker R. Emergency hospital admissions in idiopathic\n                    Parkinson\u2019s disease. Mov Disord. 2005;20(9):1104\u20138.","journal-title":"Mov Disord"},{"issue":"5","key":"152_CR64","doi-asserted-by":"publisher","first-page":"423","DOI":"10.5114\/ninp.2013.38222","volume":"47","author":"M Rudzinska","year":"2013","unstructured":"Rudzinska M, Bukowczan S, Stozek J, et al. Causes and consequences\n                    of falls in Parkinson disease patients in a prospective study. Neurol Neurochir\n                    Pol. 2013;47(5):423\u201330.","journal-title":"Neurol Neurochir Pol"},{"issue":"5","key":"152_CR65","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/13696998.2017.1284668","volume":"20","author":"C Francois","year":"2017","unstructured":"Francois C, Biaggioni I, Shibao C, et al. Fall-related healthcare\n                    use and costs in neurogenic orthostatic hypotension with Parkinson\u2019s disease. J\n                    Med Econ. 2017;20(5):525\u201332.","journal-title":"J Med Econ."},{"issue":"18","key":"152_CR66","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJM199710303371806","volume":"337","author":"ME Tinetti","year":"1997","unstructured":"Tinetti ME, Williams CS. Falls, injuries due to falls, and the risk\n                    of admission to a nursing home. N Engl J Med.\n                    1997;337(18):1279\u201384.","journal-title":"N Engl J Med"},{"issue":"2","key":"152_CR67","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s10286-005-0253-z","volume":"15","author":"C Magerkurth","year":"2005","unstructured":"Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure\n                    in Parkinson\u2019s disease: prevalence and impact on daily life. Clin Auton Res.\n                    2005;15(2):76\u201382.","journal-title":"Clin Auton Res"},{"issue":"12","key":"152_CR68","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11910-015-0599-0","volume":"15","author":"KE McDonell","year":"2015","unstructured":"McDonell KE, Shibao CA, Claassen DO. Clinical relevance of\n                    orthostatic hypotension in neurodegenerative disease. Curr Neurol Neurosci Rep.\n                    2015;15(12):78.","journal-title":"Curr Neurol Neurosci Rep."},{"key":"152_CR69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.parkreldis.2017.11.344","volume":"47","author":"A Merola","year":"2017","unstructured":"Merola A, Sawyer RP, Artusi CA, et al. Orthostatic hypotension in\n                    Parkinson disease: impact on health care utilization. Parkinson Relat Disord.\n                    2017;47:45\u20139.","journal-title":"Parkinson Relat Disord."},{"issue":"19","key":"152_CR70","doi-asserted-by":"publisher","first-page":"e008976","DOI":"10.1161\/JAHA.118.008976","volume":"7","author":"T McNicholas","year":"2018","unstructured":"McNicholas T, Tobin K, Carey D, O\u2019Callaghan S, Kenny RA. Is\n                    baseline orthostatic hypotension associated with a decline in global cognitive\n                    performance at 4-year follow-up? Data from TILDA (The Irish Longitudinal Study\n                    on Ageing). J Am Heart Assoc. 2018;7(19):e008976.","journal-title":"J Am Heart Assoc."},{"issue":"12","key":"152_CR71","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/jnnp-2016-314123","volume":"87","author":"SJ Udow","year":"2016","unstructured":"Udow SJ, Robertson AD, MacIntosh BJ, et al. \u2018Under pressure\u2019: is\n                    there a link between orthostatic hypotension and cognitive impairment in\n                    alpha-synucleinopathies? J Neurol Neurosurg Psychiatry.\n                    2016;87(12):1311\u201321.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"152_CR72","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/mds.26632","volume":"31","author":"C McDonald","year":"2016","unstructured":"McDonald C, Newton JL, Burn DJ. Orthostatic hypotension and\n                    cognitive impairment in Parkinson\u2019s disease: causation or association? Mov\n                    Disord. 2016;31(7):937\u201346.","journal-title":"Mov Disord"},{"issue":"1","key":"152_CR73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1212\/WNL.0000000000003452","volume":"88","author":"J Centi","year":"2017","unstructured":"Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO,\n                    Cronin-Golomb A. Effects of orthostatic hypotension on cognition in Parkinson\n                    disease. Neurology. 2017;88(1):17\u201324.","journal-title":"Neurology."},{"issue":"3","key":"152_CR74","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4065\/80.3.330","volume":"80","author":"C Schrezenmaier","year":"2005","unstructured":"Schrezenmaier C, Gehrking JA, Hines SM, Low PA, Benrud-Larson LM,\n                    Sandroni P. Evaluation of orthostatic hypotension: relationship of a new\n                    self-report instrument to laboratory-based measures. Mayo Clin Proc.\n                    2005;80(3):330\u20134.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"152_CR75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10286-011-0146-2","volume":"22","author":"H Kaufmann","year":"2012","unstructured":"Kaufmann H, Malamut R, Norcliffe-Kaufmann L, Rosa K, Freeman R. The\n                    Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom\n                    assessment scale. Clin Auton Res. 2012;22(2):79\u201390.","journal-title":"Clin Auton Res"},{"issue":"3","key":"152_CR76","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/jch.12062","volume":"15","author":"C Shibao","year":"2013","unstructured":"Shibao C, Lipsitz LA, Biaggioni I. ASH position paper: evaluation\n                    and treatment of orthostatic hypotension. J Clin Hypertens (Greenwich).\n                    2013;15(3):147\u201353.","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"5","key":"152_CR77","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/HJH.0000000000001265","volume":"35","author":"BH Shaw","year":"2017","unstructured":"Shaw BH, Garland EM, Black BK, et al. Optimal diagnostic thresholds\n                    for diagnosis of orthostatic hypotension with a \u2018sit-to-stand test\u2019. J\n                    Hypertens. 2017;35(5):1019\u201325.","journal-title":"J Hypertens"},{"issue":"11","key":"152_CR78","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/00004872-199511000-00011","volume":"13","author":"F Loew","year":"1995","unstructured":"Loew F, Gauthey L, Koerffy A, et al. Postprandial hypotension and\n                    orthostatic blood pressure responses in elderly Parkinson\u2019s disease patients. J\n                    Hypertens. 1995;13(11):1291\u20137.","journal-title":"J Hypertens"},{"issue":"3","key":"152_CR79","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1212\/WNL.37.3.386","volume":"37","author":"G Micieli","year":"1987","unstructured":"Micieli G, Martignoni E, Cavallini A, Sandrini G, Nappi G.\n                    Postprandial and orthostatic hypotension in Parkinson\u2019s disease. Neurology.\n                    1987;37(3):386\u201393.","journal-title":"Neurology."},{"key":"152_CR80","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ijcard.2018.05.043","volume":"271","author":"DJL van Twist","year":"2018","unstructured":"van Twist DJL, Dinh T, Bouwmans EME, Kroon AA. Initial orthostatic\n                    hypotension among patients with unexplained syncope: an overlooked diagnosis?\n                    Int J Cardiol. 2018;271:269\u201373.","journal-title":"Int J Cardiol"},{"issue":"3","key":"152_CR81","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.25170","volume":"83","author":"L Norcliffe-Kaufmann","year":"2018","unstructured":"Norcliffe-Kaufmann L, Kaufmann H, Palma JA, et al. Orthostatic\n                    heart rate changes in patients with autonomic failure caused by\n                    neurodegenerative synucleinopathies. Ann Neurol.\n                    2018;83(3):522\u201331.","journal-title":"Ann Neurol"},{"issue":"6","key":"152_CR82","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/ana.25363","volume":"84","author":"P Balagny","year":"2018","unstructured":"Balagny P, Wanono R, d\u2019Ortho MP, Vidal-Petiot E. Reply to\n                    validation of the new diagnostic tests for neurogenic orthostatic hypotension.\n                    Ann Neurol. 2018;84(6):957\u20138.","journal-title":"Ann Neurol"},{"issue":"9","key":"152_CR83","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1007\/s00415-012-6736-7","volume":"260","author":"M Metzler","year":"2013","unstructured":"Metzler M, Duerr S, Granata R, Krismer F, Robertson D, Wenning GK.\n                    Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management.\n                    J Neurol. 2013;260(9):2212\u20139.","journal-title":"J Neurol"},{"issue":"1","key":"152_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2013.9.1.1","volume":"9","author":"PA Low","year":"2013","unstructured":"Low PA, Tomalia VA, Park KJ. Autonomic function tests: some\n                    clinical applications. J Clin Neurol. 2013;9(1):1\u20138.","journal-title":"J Clin Neurol."},{"issue":"11","key":"152_CR85","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1185\/03007995.2015.1087988","volume":"31","author":"A Loavenbruck","year":"2015","unstructured":"Loavenbruck A, Sandroni P. Neurogenic orthostatic hypotension:\n                    roles of norepinephrine deficiency in its causes, its treatment, and future\n                    research directions. Curr Med Res Opin. 2015;31(11):2095\u2013104.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"152_CR86","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/archneurol.2009.71","volume":"66","author":"A Lipp","year":"2009","unstructured":"Lipp A, Sandroni P, Ahlskog JE, et al. Prospective differentiation\n                    of multiple system atrophy from Parkinson disease, with and without autonomic\n                    failure. Arch Neurol. 2009;66(6):742\u201350.","journal-title":"Arch Neurol"},{"issue":"8","key":"152_CR87","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S0025-6196(12)60631-4","volume":"68","author":"PA Low","year":"1993","unstructured":"Low PA. Composite autonomic scoring scale for laboratory\n                    quantification of generalized autonomic failure. Mayo Clin Proc.\n                    1993;68(8):748\u201352.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"152_CR88","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0404.1990.tb01568.x","volume":"81","author":"M Camerlingo","year":"1990","unstructured":"Camerlingo M, Ferraro B, Gazzaniga GC, Casto L, Cesana BM, Mamoli\n                    A. Cardiovascular reflexes in Parkinson\u2019s disease: long-term effects of levodopa\n                    treatment on de novo patients. Acta Neurol Scand.\n                    1990;81(4):346\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"5694","key":"152_CR89","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/bmj.1.5694.474","volume":"1","author":"DB Calne","year":"1970","unstructured":"Calne DB, Brennan J, Spiers AS, Stern GM. Hypotension caused\n                        by L-dopa. Br Med J.\n                    1970;1(5694):474\u20135.","journal-title":"Br Med J"},{"issue":"2","key":"152_CR90","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1353-8020(98)00014-5","volume":"4","author":"WH Jost","year":"1998","unstructured":"Jost WH, Bellon AK, Kaiser T, Schrank B. The impact of ropinirole\n                    on blood pressure and noradrenaline concentration after active orthostasis in\n                    Parkinsonian patients. Parkinson Relat Disord. 1998;4(2):61\u20133.","journal-title":"Parkinson Relat Disord."},{"issue":"1\u20132","key":"152_CR91","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.autneu.2004.06.009","volume":"116","author":"M Bouhaddi","year":"2004","unstructured":"Bouhaddi M, Vuillier F, Fortrat JO, et al. Impaired cardiovascular\n                    autonomic control in newly and long-term-treated patients with Parkinson\u2019s\n                    disease: involvement of L-dopa therapy.\n                    Auton Neurosci. 2004;116(1\u20132):30\u20138.","journal-title":"Auton Neurosci."},{"issue":"13","key":"152_CR92","first-page":"59","volume":"101","author":"A Barbeau","year":"1969","unstructured":"Barbeau A. L-dopa therapy in\n                    Parkinson\u2019s disease: a critical review of nine years\u2019 experience. Can Med Assoc\n                    J. 1969;101(13):59\u201368.","journal-title":"Can Med Assoc J"},{"issue":"11","key":"152_CR93","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s004150070075","volume":"247","author":"TH Haapaniemi","year":"2000","unstructured":"Haapaniemi TH, Kallio MA, Korpelainen JT, et al. Levodopa,\n                    bromocriptine and selegiline modify cardiovascular responses in Parkinson\u2019s\n                    disease. J Neurol. 2000;247(11):868\u201374.","journal-title":"J Neurol"},{"issue":"2","key":"152_CR94","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/1531-8257(199903)14:2<246::AID-MDS1008>3.0.CO;2-P","volume":"14","author":"A Churchyard","year":"1999","unstructured":"Churchyard A, Mathias CJ, Lees AJ. Selegiline-induced postural\n                    hypotension in Parkinson\u2019s disease: a longitudinal study on the effects of drug\n                    withdrawal. Mov Disord. 1999;14(2):246\u201351.","journal-title":"Mov Disord"},{"key":"152_CR95","volume-title":"Miraprex\u00ae (pramipexole dihydrochloride). Full prescribing information","author":"Boehringer Ingelheim Pharmaceuticals, Inc.","year":"2007","unstructured":"Boehringer Ingelheim Pharmaceuticals, Inc. Miraprex\u00ae (pramipexole\n                    dihydrochloride). Full prescribing information. Ridgefield: Boehringer Ingelheim\n                    Pharmaceuticals, Inc; 2007."},{"key":"152_CR96","volume-title":"Miraprex ER\u00ae (pramipexole dihydrochloride). Full prescribing information","author":"Boehringer Ingelheim Pharmaceuticals, Inc.","year":"2014","unstructured":"Boehringer Ingelheim Pharmaceuticals, Inc. Miraprex ER\u00ae\n                    (pramipexole dihydrochloride). Full prescribing information. Ridgefield:\n                    Boehringer Ingelheim Pharmaceuticals, Inc; 2014."},{"key":"152_CR97","volume-title":"Parlodel\u00ae (Bromocriptine mesylate). Full prescribing information","author":"Novartis International AG","year":"2011","unstructured":"Novartis International AG. Parlodel\u00ae (Bromocriptine mesylate). Full\n                    prescribing information. Suffern: Novartis International AG;\n                    2011."},{"key":"152_CR98","volume-title":"Rasagiline (rasagiline). Full prescribing information","author":"Teva Pharmaceuticals","year":"2019","unstructured":"Teva Pharmaceuticals. Rasagiline (rasagiline). Full prescribing\n                    information. Parsippany: Teva Pharmaceuticals; 2019."},{"key":"152_CR99","volume-title":"REQUIP (ropinirole). Full prescribing information","author":"GlaxoSmithKline","year":"2018","unstructured":"GlaxoSmithKline. REQUIP (ropinirole). Full prescribing information.\n                    Research Triangle Park: GlaxoSmithKline; 2018."},{"key":"152_CR100","volume-title":"Sinemet\u00ae (carbidopa levodopa). Full prescribing information","author":"Merck & Co., Inc.","year":"2018","unstructured":"Merck & Co., Inc. Sinemet\u00ae (carbidopa levodopa). Full\n                    prescribing information. Whitehouse Station: Merck & Co., Inc.; 2018. https:\/\/www.merck.com\/product\/usa\/pi_circulars\/s\/sinemet\/sinemet_pi.pdf"},{"key":"152_CR101","volume-title":"ZELAPAR\u00ae (selegiline hydrochloride). Full prescribing information","author":"Valeant Pharmaceuticals","year":"2008","unstructured":"Valeant Pharmaceuticals. ZELAPAR\u00ae (selegiline hydrochloride). Full\n                    prescribing information. Aliso Viejo: Valeant Pharmaceuticals;\n                    2008."},{"key":"152_CR102","volume-title":"GOCOVRI\u2122 (amantadine). Full prescribing information","author":"Adamas Pharma, LLC","year":"2017","unstructured":"Adamas Pharma, LLC. GOCOVRI\u2122 (amantadine). Full prescribing\n                    information. Emeryville: Adamas Pharma, LLC; 2017."},{"issue":"8","key":"152_CR103","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jamaneurol.2017.0943","volume":"74","author":"R Pahwa","year":"2017","unstructured":"Pahwa R, Tanner CM, Hauser RA, et al. ADS-5102 (amantadine)\n                    extended-release capsules for levodopa-induced dyskinesia in Parkinson disease\n                    (EASE LID Study): a randomized clinical trial. JAMA Neurol.\n                    2017;74(8):941\u20139.","journal-title":"JAMA Neurol."},{"issue":"12","key":"152_CR104","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/mds.27131","volume":"32","author":"W Oertel","year":"2017","unstructured":"Oertel W, Eggert K, Pahwa R, et al. Randomized, placebo-controlled\n                    trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced\n                    dyskinesia in Parkinson\u2019s disease (EASE LID 3). Mov Disord.\n                    2017;32(12):1701\u20139.","journal-title":"Mov Disord"},{"issue":"6","key":"152_CR105","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1161\/01.HYP.0000188052.69549.e4","volume":"46","author":"DS Goldstein","year":"2005","unstructured":"Goldstein DS, Eldadah BA, Holmes C, et al. Neurocirculatory\n                    abnormalities in Parkinson disease with orthostatic hypotension: independence\n                    from levodopa treatment. Hypertension. 2005;46(6):1333\u20139.","journal-title":"Hypertension"},{"issue":"2","key":"152_CR106","doi-asserted-by":"publisher","first-page":"97","DOI":"10.14802\/jmd.16001","volume":"9","author":"JS Kim","year":"2016","unstructured":"Kim JS, Lee SH, Oh YS, et al. Cardiovascular autonomic dysfunction\n                    in mild and advanced Parkinson\u2019s disease. J Mov Disord.\n                    2016;9(2):97\u2013103.","journal-title":"J Mov Disord."},{"issue":"1","key":"152_CR107","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1034\/j.1600-0404.2003.00172.x","volume":"109","author":"A Korchounov","year":"2004","unstructured":"Korchounov A, Kessler KR, Schipper HI. Differential effects of\n                    various treatment combinations on cardiovascular dysfunction in patients with\n                    Parkinson\u2019s disease. Acta Neurol Scand. 2004;109(1):45\u201351.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"152_CR108","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/j.jacc.2017.03.003","volume":"70","author":"WK Shen","year":"2017","unstructured":"Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC\/AHA\/HRS guideline\n                    for the evaluation and management of patients with syncope: a report of the\n                    American College of Cardiology\/American Heart Association Task Force on clinical\n                    practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol.\n                    2017;70(5):e39\u2013110.","journal-title":"J Am Coll Cardiol"},{"issue":"827","key":"152_CR109","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/pgmj.70.827.638","volume":"70","author":"GM Craig","year":"1994","unstructured":"Craig GM. Clinical presentation of orthostatic hypotension in the\n                    elderly. Postgrad Med J. 1994;70(827):638\u201342.","journal-title":"Postgrad Med J"},{"issue":"5","key":"152_CR110","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.parkreldis.2012.01.012","volume":"18","author":"S Perez-Lloret","year":"2012","unstructured":"Perez-Lloret S, Rey MV, Fabre N, et al. Factors related to\n                    orthostatic hypotension in Parkinson\u2019s disease. Parkinson Relat Disord.\n                    2012;18(5):501\u20135.","journal-title":"Parkinson Relat Disord."},{"issue":"7","key":"152_CR111","doi-asserted-by":"publisher","first-page":"e652","DOI":"10.1212\/WNL.0000000000005994","volume":"91","author":"JL Newton","year":"2018","unstructured":"Newton JL, Frith J. The efficacy of non-pharmacologic intervention\n                    for orthostatic hypotension associated with aging. Neurology.\n                    2018;91(7):e652\u20136.","journal-title":"Neurology."},{"issue":"2","key":"152_CR112","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.apmr.2014.09.028","volume":"96","author":"PB Mills","year":"2015","unstructured":"Mills PB, Fung CK, Travlos A, Krassioukov A. Nonpharmacologic\n                    management of orthostatic hypotension: a systematic review. Arch Phys Med\n                    Rehabil. 2015;96(2):366\u201375.","journal-title":"Arch Phys Med Rehabil"},{"key":"152_CR113","volume-title":"NORTHERA\u00ae (droxidopa)","author":"Lundbeck NA Ltd","year":"2017","unstructured":"Lundbeck NA Ltd. NORTHERA\u00ae (droxidopa).\n                    Deerfield: Lundbeck NA Ltd; 2017."},{"key":"152_CR114","volume-title":"ProAmatine\u00ae (midodrine hydrochloride). Full prescribing information","author":"Shire US Inc.","year":"2017","unstructured":"Shire US Inc. ProAmatine\u00ae (midodrine\n                    hydrochloride). Full prescribing information. Lexington: Shire US Inc.;\n                    2017."},{"issue":"5","key":"152_CR115","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/mds.26086","volume":"30","author":"RA Hauser","year":"2015","unstructured":"Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Droxidopa for\n                    the short-term treatment of symptomatic neurogenic orthostatic hypotension in\n                    Parkinson\u2019s disease (nOH306B). Mov Disord. 2015;30(5):646\u201354.","journal-title":"Mov Disord"},{"issue":"4","key":"152_CR116","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","volume":"83","author":"H Kaufmann","year":"2014","unstructured":"Kaufmann H, Freeman R, Biaggioni I, et al. Droxidopa for neurogenic\n                    orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.\n                    Neurology. 2014;83(4):328\u201335.","journal-title":"Neurology."},{"issue":"1","key":"152_CR117","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12883-017-0867-5","volume":"17","author":"I Biaggioni","year":"2017","unstructured":"Biaggioni I, Arthur Hewitt L, Rowse GJ, Kaufmann H. Integrated\n                    analysis of droxidopa trials for neurogenic orthostatic hypotension. BMC Neurol.\n                    2017;17(1):90.","journal-title":"BMC Neurol."},{"issue":"6","key":"152_CR118","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/mdc3.12695","volume":"5","author":"RA Hauser","year":"2018","unstructured":"Hauser RA, Biaggioni I, Hewitt LA, Vernino S. Integrated analysis\n                    of droxidopa for the treatment of neurogenic orthostatic hypotension in patients\n                    with Parkinson disease. Mov Disord Clin Pract.\n                    2018;5(6):627\u201334.","journal-title":"Mov Disord Clin Pract."},{"issue":"3","key":"152_CR119","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mdc3.12726","volume":"6","author":"C Fran\u00e7ois","year":"2019","unstructured":"Fran\u00e7ois C, Shibao CA, Biaggioni I, et al. Six-month use of\n                    droxidopa for neurogenic orthostatic hypotension. Mov Disord Clin Pract.\n                    2019;6(3):235\u201342.","journal-title":"Mov Disord Clin Pract."},{"issue":"5","key":"152_CR120","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/WNF.0000000000000168","volume":"39","author":"RA Hauser","year":"2016","unstructured":"Hauser RA, Heritier S, Rowse GJ, Hewitt LA, Isaacson SH. Droxidopa\n                    and reduced falls in a trial of Parkinson patients with neurogenic orthostatic\n                    hypotension. Clin Neuropharmacol. 2016;39(5):220\u20136.","journal-title":"Clin Neuropharmacol"},{"issue":"16","key":"152_CR121","doi-asserted-by":"publisher","first-page":"e1539","DOI":"10.1212\/WNL.0000000000006369","volume":"91","author":"JA Palma","year":"2018","unstructured":"Palma JA, Norcliffe-Kaufmann L, Martinez J, Kaufmann H. Supine\n                    plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic\n                    hypotension. Neurology. 2018;91(16):e1539\u201344.","journal-title":"Neurology."},{"issue":"12","key":"152_CR122","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1177\/1060028018786954","volume":"52","author":"JJ Chen","year":"2018","unstructured":"Chen JJ, Han Y, Tang J, Portillo I, Hauser RA, Dashtipour K.\n                    Standing and supine blood pressure outcomes associated with droxidopa and\n                    midodrine in patients with neurogenic orthostatic hypotension: a Bayesian\n                    meta-analysis and mixed treatment comparison of randomized trials. Ann\n                    Pharmacother. 2018;52(12):1182\u201394.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"152_CR123","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1212\/WNL.51.1.120","volume":"51","author":"RA Wright","year":"1998","unstructured":"Wright RA, Kaufmann HC, Perera R, et al. A double-blind,\n                    dose-response study of midodrine in neurogenic orthostatic hypotension.\n                    Neurology. 1998;51(1):120\u20134.","journal-title":"Neurology."},{"issue":"13","key":"152_CR124","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","volume":"277","author":"PA Low","year":"1997","unstructured":"Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of\n                    midodrine vs placebo in neurogenic orthostatic hypotension. A randomized,\n                    double-blind multicenter study. Midodrine Study Group. JAMA.\n                    1997;277(13):1046\u201351.","journal-title":"JAMA."},{"issue":"12","key":"152_CR125","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00702-017-1791-y","volume":"124","author":"S Eschlbock","year":"2017","unstructured":"Eschlbock S, Wenning G, Fanciulli A. Evidence-based treatment of\n                    neurogenic orthostatic hypotension and related symptoms. J Neural Transm\n                    (Vienna). 2017;124(12):1567\u2013605.","journal-title":"J Neural Transm (Vienna)."},{"key":"152_CR126","volume-title":"AvPAK (fludrocortisone acetate). Full prescribing information","author":"AvKARE, Inc.","year":"2018","unstructured":"AvKARE, Inc. AvPAK (fludrocortisone acetate). Full prescribing\n                    information. Pulaski: AvKARE, Inc.; 2018."},{"key":"152_CR127","unstructured":"Valeant Pharmaceuticals North America LLC. Mestinon\n                    (pyridostigmine). Prescribing information, Bridgewater: Valeant Pharmaceuticals\n                    North America LLC; 2013."},{"issue":"1","key":"152_CR128","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.107.091355","volume":"50","author":"C Shibao","year":"2007","unstructured":"Shibao C, Gamboa A, Diedrich A, et al. Acarbose, an\n                    alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic\n                    failure. Hypertension. 2007;50(1):54\u201361.","journal-title":"Hypertension"},{"issue":"7","key":"152_CR129","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jacc.2015.06.1084","volume":"66","author":"F Ricci","year":"2015","unstructured":"Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension:\n                    epidemiology, prognosis, and treatment. J Am Coll Cardiol.\n                    2015;66(7):848\u201360.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"152_CR130","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1365-2796.1992.tb00563.x","volume":"232","author":"AD Ten Harkel","year":"1992","unstructured":"Ten Harkel AD, Van Lieshout JJ, Wieling W. Treatment of orthostatic\n                    hypotension with sleeping in the head-up tilt position, alone and in combination\n                    with fludrocortisone. J Intern Med. 1992;232(2):139\u201345.","journal-title":"J Intern Med"},{"issue":"9","key":"152_CR131","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(16)30079-5","volume":"15","author":"AJ Espay","year":"2016","unstructured":"Espay AJ, LeWitt PA, Hauser RA, Merola A, Masellis M, Lang AE.\n                    Neurogenic orthostatic hypotension and supine hypertension in Parkinson\u2019s\n                    disease and related synucleinopathies: prioritisation of treatment targets.\n                    Lancet Neurol. 2016;15(9):954\u201366.","journal-title":"Lancet Neurol."},{"issue":"1","key":"152_CR132","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10286-009-0522-3","volume":"19","author":"W Wieling","year":"2009","unstructured":"Wieling W, Raj SR, Thijs RD. Are small observational studies\n                    sufficient evidence for a recommendation of head-up sleeping in all patients\n                    with debilitating orthostatic hypotension? MacLean and Allen revisited after\n                    70\u00a0years. Clin Auton Res. 2009;19(1):8\u201312.","journal-title":"Clin Auton Res"},{"issue":"8","key":"152_CR133","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1097\/HJH.0000000000002078","volume":"37","author":"J Jordan","year":"2019","unstructured":"Jordan J, Fanciulli A, Tank J, et al. Management of supine\n                    hypertension in patients with neurogenic orthostatic hypotension: scientific\n                    statement of the American Autonomic Society, European Federation of Autonomic\n                    Societies, and the European Society of Hypertension. J Hypertens.\n                    2019;37(8):1541\u20136.","journal-title":"J Hypertens."}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-019-00152-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-019-00152-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-019-00152-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T22:09:40Z","timestamp":1717625380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-019-00152-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":133,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["152"],"URL":"https:\/\/doi.org\/10.1007\/s40120-019-00152-9","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"26 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}